selective eligibility and enrollment of patients that are younger and fitter than the average of the CLL population [ 26 , 27 ]. The risk and consequences of infections in CLL patients could also be changing because of the increasing use of less toxic and more effective targeted therapy [ 28 ] that have decreased the rate of serious infections following initiation of therapy [ 29 ]. With increased CLL patient survival, the lifetime risk of infections is increasing and complications not recognized as severe adverse effects by standardized criteria (e.g., shingles
Both incidence and mortality of colorectal cancer (CRC) in Romania have shown a continuous increase during the last decades. Hereditary Non-Polyposic Colorectal Cancer (HNPCC), also known as Lynch syndrome, is mainly attributable to mismatch repair (MMR) genes MSH2, MSH6, and MLH1. Individuals carrying germ-line mutations of these genes present high lifetime risk of colorectal and other cancers, compared to non-carriers. Oncogenetics is developed worldwide nowadays, for identifying hereditary predisposition to cancer and offering appropriate clinical follow-up to patients and mutation carriers in Lynch families. Molecular oncogenetic diagnosis in Lynch syndrome is based on complete Sanger sequencing of entire MMR genes, which is time and resources consuming, therefore needing an appropriate and adapted optimization. Conventional sequencing requires a sufficient number of available samples to be processed simultaneously, which increases the waiting time for diagnostic results. Complete analysis for only one patient meets difficult technical problems due to the complex co-amplification of all gene regions of interest within the same conditions, therefore increasing the costs and reducing the cost-effectiveness of the test. Here we present an original and robust technical protocol for sequencing the entire MSH2, MSH6, and MLH1 coding sequence for one patient in a single PCR plate. Our optimized and verified system overcomes all technical problems and offers a quick, robust, and cost-effective possibility to personalize molecular oncogenetic diagnosis in Lynch syndrome.
Margit Șerban, Dan Poenaru, Laura Cernat, Delia Savescu, Jenel Pătrașcu, Wolfgang Schramm, Emilia Ursu, Delia Mihailov, Cristian Jinca, Ioana Ioniță and Smaranda Arghirescu
/3 multicenter clinical trial in severe hemophilia A. Blood. 2016; 128 (5): 630-637. DOI: 10.1182/blood-2016-01-687434
16. Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia. 2005; 11 (1):1-6. DOI: 10.1111/j.1365-2516.2005.01156.x
17. Négrier C, Gomperts ED, Oldenburg J. The history of FEIBA: a lifetime of success in the treatment of haemophilia complicated by an inhibitor. Haemophilia. 2006;12:4-13. DOI: 10.1111/j.1365
Alexander Čanády, Ladislav Mošanský and Peter Krišovský
squirrels (Sciurus vulgaris). Ethol. Ecol.
Evol., 2, 195-204.
Wauters, L.A. & Dhondt, A.A. (1992) Spacing behaviour of red squirrels,
Sciurus vulgaris: variation between habitats and the sexes. Anim.
Behav., 43, 297-311.
Wauters, L.A. & Dhondt, A.A. (1995) Lifetime reproductive success and
its correlates in female Eurasian red squirrels. Oikos, 72, 402-
Wauters, L.A., Zaninetti, M., Tosi, G. & Bertolino, S. (2004) Is coat-colour
polymorphism in Eurasian red squirrels (Sciurus vulgaris L.)
adaptive? Mammalia, 68, 37-48.
Wauters, L.A., Vermeulen, M., Van Dongen, S